Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release

Source: Psychopharmacology - Category: Psychiatry Source Type: research
More News: Abilify | COVID-19 | Psychiatry